Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06323499
Status:
COMPLETED
Last Update Posted:
2024-04-24
First Post:
2024-03-14
Brief Title:
Outcome of Induced Atypical Atrial Flutter
Sponsor:
University Hospital Essen
Organization:
University Hospital Essen
Study Overview
Official Title:
Outcome After Ablation of Atypical Atrial Flutter is Induction a Feasible Approach
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background Atypical atrial flutter AAF is an increasingly relevant clinical problem Despite advancements in mapping and ablation techniques the general management of these patients remain challenging especially when mapping cannot be performed during ongoing arrhythmia There are no data whether induction of AAF is a feasible approach in these cases
Methods The investigators retrospectively analyzed patients who underwent catheter ablation of AAF and compared procedural results between patients with ongoing tachycardia when starting the procedure and patients with induced AAF
For this retrospective study the investigators analyzed patients undergoing ablation of AAF between April 2018 and January 2021 that were identified from the ablation database at the West German Heart and Vascular Center Essen All patients were followed up in the outpatient clinic as part of the clinical standard routine or contacted by telephone to assess the occurrence of clinical recurrence of any arrhythmia In case the documentation was not performed at the institution relevant documents and ECGs were requested and reviewed
This single-center cohort study was conducted at the University Hospital Essen Germany in accordance with the Declaration of Helsinki and its amendments and was approved by the institutional review board of the University of Essen number 21-10341-BO Written informed consent was obtained from all study participants
The primary study endpoint was to evaluate the outcome of patients with induced AAF in comparison to patients with ongoing AAF when starting the procedure Furthermore the investigators analyzed the type of recurrence during follow-up as well as the occurrence and results of repeat ablations at the institution The investigators also evaluated if the recurrent AAF form was the same or de-novo compared to the AAF during previous procedure
Methods The investigators retrospectively analyzed patients who underwent catheter ablation of AAF and compared procedural results between patients with ongoing tachycardia when starting the procedure and patients with induced AAF
For this retrospective study the investigators analyzed patients undergoing ablation of AAF between April 2018 and January 2021 that were identified from the ablation database at the West German Heart and Vascular Center Essen All patients were followed up in the outpatient clinic as part of the clinical standard routine or contacted by telephone to assess the occurrence of clinical recurrence of any arrhythmia In case the documentation was not performed at the institution relevant documents and ECGs were requested and reviewed
This single-center cohort study was conducted at the University Hospital Essen Germany in accordance with the Declaration of Helsinki and its amendments and was approved by the institutional review board of the University of Essen number 21-10341-BO Written informed consent was obtained from all study participants
The primary study endpoint was to evaluate the outcome of patients with induced AAF in comparison to patients with ongoing AAF when starting the procedure Furthermore the investigators analyzed the type of recurrence during follow-up as well as the occurrence and results of repeat ablations at the institution The investigators also evaluated if the recurrent AAF form was the same or de-novo compared to the AAF during previous procedure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None